Background and Aims: The structured IBD Ahead ‘Optimised Monitoring' programme was designed to obtain the opinion, insight and advice of gastroenterologists on optimising the monitoring of Crohn's disease activity in four settings: (1) assessment at diagnosis, (2) monitoring in symptomatic patients, (3) monitoring in asymptomatic patients, and (4) the postoperative follow-up. For each of these settings, four monitoring methods were discussed: (a) symptom assessment, (b) endoscopy, (c) laboratory markers, and (d) imaging. Based on literature search and expert opinion compiled during an international consensus meeting, recommendations were given to answer the question ‘which diagnostic method, when, and how often'. The International IBD Ahead Expert Panel advised to tailor this guidance to the healthcare system and the special prerequisites of each country. The IBD Ahead Swiss National Steering Committee proposes best-practice recommendations adapted for Switzerland. Methods: The IBD Ahead Steering Committee identified key questions and provided the Swiss Expert Panel with a structured literature research. The expert panel agreed on a set of statements. During an international expert meeting the consolidated outcome of the national meetings was merged into final statements agreed by the participating International and National Steering Committee members - the IBD Ahead ‘Optimized Monitoring' Consensus. Results: A systematic assessment of symptoms, endoscopy findings, and laboratory markers with special emphasis on faecal calprotectin is deemed necessary even in symptom-free patients. The choice of recommended imaging methods is adapted to the specific situation in Switzerland and highlights the importance of ultrasonography and magnetic resonance imaging besides endoscopy. Conclusion: The recommendations stress the importance of monitoring disease activity on a regular basis and by objective parameters, such as faecal calprotectin and endoscopy with detailed documentation of findings. Physicians should not rely on symptoms only and adapt the monitoring schedule and choice of options to individual situations.

Journal Section:
Review
Keywords:
Chronic inflammatory bowel disease, Crohn’s disease, Disease monitoring, Recommendations, Best-practice guidelines, Endoscopy, Multidetector computed tomography, Calprotectin, Small intestine contrast ultrasonography, Contrast-enhanced ultrasound
1.
Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, O'Morain C, Öresland T, Windsor A, Stange EF, Travis SPL: The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis 2010;4:28-62.
[PubMed]
https://doi.org/10.1016/j.crohns.2009.12.002
2.
Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E: The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010;4:7-27.
[PubMed]
https://doi.org/10.1016/j.crohns.2009.12.003
3.
Ferrante M, Karmiris K, Newnham E, Siffledeen J, Zelinkova Z, van Assche G, Lakatos PL, Panés J, Sturm A, Travis S, van der Woude CJ, Reinisch W, Colombel JF, Panaccione R: Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme. J Crohns Colitis 2012;6:116-131.
[PubMed]
https://doi.org/10.1016/j.crohns.2011.09.009
4.
Best WR, Becktel JM, Singleton JW: Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77:843-846.
[PubMed]
5.
Best WR: Predicting the Crohn's Disease Activity Index from the Harvey-Bradshaw Index. Inflamm Bowel Dis 2006;12:304-310.
[PubMed]
https://doi.org/10.1097/01.MIB.0000215091.77492.2a
6.
Irvine EJ: Quality of life - measurement in inflammatory bowel disease. Scand J Gastroenterol Suppl 1993;199:36-39.
[PubMed]
https://doi.org/10.3109/00365529309098355
7.
Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JW: Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994;106:287-296.
[PubMed]
8.
Irvine EJ: Quality of Life in inflammatory bowel disease: biases and other factors affecting scores. Scand J Gastroenterol Suppl 1995;208:136-140.
[PubMed]
https://doi.org/10.3109/00365529509107776
9.
Irvine EJ, Zhou Q, Thompson AK: The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996;91:1571-1578.
[PubMed]
10.
Pera A, Bellando P, Caldera D, Ponti V, Astegiano M, Barletti C, David E, Arrigoni A, Rocca G, Verme G: Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987;92:181-185.
[PubMed]
11.
Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Schulz T, Stray N, Fausa O: Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population-based study in south eastern Norway. Gut 1997;40:328-332.
[PubMed]
12.
Surawicz CM, Belic L: Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 1984;86:104-113.
[PubMed]
13.
Chang DK, Kim JJ, Choi H, Eun CS, Han DS, Byeon JS, Kim JO: Double balloon endoscopy in small intestinal Crohn's disease and other inflammatory diseases such as cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). Gastrointest Endosc 2007;66(3 suppl):S96-S98.
[PubMed]
https://doi.org/10.1016/j.gie.2007.01.016
14.
Kondo J, Iijima H, Abe T, Komori M, Hiyama S, Ito T, Nakama A, Tominaga K, Kubo M, Suzuki K, Iwanaga Y, Ebara R, Takeda A, Tsuji S, Nishida T, Tsutsui S, Tsujii M, Hayashi N: Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease: a multicenter experience. J Gastroenterol 2010;45:713-720.
[PubMed]
https://doi.org/10.1007/s00535-010-0216-6
15.
Manes G, Bianchi Porro G: Missed lesions with conventional endoscopy discovered by double-balloon enteroscopy: endoscopist or instrument? Aliment Pharmacol Ther 2009;29:918-919; author reply 919-920.
[PubMed]
https://doi.org/10.1111/j.1365-2036.2009.03939.x
16.
Sunada K, Yamamoto H, Yano T, Sugano K: Advances in the diagnosis and treatment of small bowel lesions with Crohn's disease using double-balloon endoscopy. Therap Adv Gastroenterol 2009;2:357-366.
[PubMed]
https://doi.org/10.1177/1756283X09343542
17.
Cameron DJ: Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: a prospective study. J Gastroenterol Hepatol 1991;6:355-358.
[PubMed]
https://doi.org/10.1111/j.1440-1746.1991.tb00870.x
18.
Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA: Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease. Am J Gastroenterol 1997;92:1467-1471.
[PubMed]
19.
Isaacs KL: Upper gastrointestinal tract endoscopy in inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002;12:451-462, vii.
[PubMed]
https://doi.org/10.1016/S1052-5157(02)00006-5
20.
Castellaneta SP, Afzal NA, Greenberg M, Deere H, Davies S, Murch SH, Walker-Smith JA, Thomson M, Srivistrava A: Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004;39:257-261.
[PubMed]
https://doi.org/10.1097/00005176-200409000-00006
21.
Bourreille A, Ignjatovic A, Aabakken L, Loftus EV Jr, Eliakim R, Pennazio M, Bouhnik Y, Seidman E, Keuchel M, Albert JG, Ardizzone S, Bar-Meir S, Bisschops R, Despott EJ, Fortun PF, Heuschkel R, Kammermeier J, Leighton JA, Mantzaris GJ, Moussata D, Lo S, Paulsen V, Panés J, Radford-Smith G, Reinisch W, Rondonotti E, Sanders DS, Swoger JM, Yamamoto H, Travis S, Colombel JF, Van Gossum A: Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009;41:618-637.
[PubMed]
https://doi.org/10.1055/s-0029-1214790
22.
Annunziata ML, Caviglia R, Papparella LG, Cicala M: Upper gastrointestinal involvement of Crohn's disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci 2012;57:1618-1623.
[PubMed]
https://doi.org/10.1007/s10620-012-2072-0
23.
Fireman Z, Mahajna E, Broide E, Shapiro M, Fich L, Sternberg A, Kopelman Y, Scapa E: Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut 2003;52:390-392.
[PubMed]
https://doi.org/10.1136/gut.52.3.390
24.
Herrerías JM, Caunedo A, Rodríguez-Téllez M, Pellicer F, Herrerías JM Jr: Capsule endoscopy in patients with suspected Crohn's disease and negative endoscopy. Endoscopy 2003;35:564-568.
[PubMed]
https://doi.org/10.1055/s-2003-40241
25.
Schulmann K, Hollerbach S, Schmiegel W: Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut 2003;52:1531-1532; author reply 1532.
[PubMed]
https://doi.org/10.1136/gut.52.10.1531-b
26.
Eliakim R, Adler SN: Capsule video endoscopy in Crohn's disease - the European experience. Gastrointest Endosc Clin N Am 2004;14:129-137.
[PubMed]
https://doi.org/10.1016/j.giec.2003.10.019
27.
Jungles SL: Video wireless capsule endoscopy: a diagnostic tool for early Crohn's disease. Gastroenterol Nurs 2004;27:170-175.
[PubMed]
https://doi.org/10.1097/00001610-200407000-00005
28.
Albert JG, Martiny F, Krummenerl A, Stock K, Lesske J, Göbel CM, Lotterer E, Nietsch HH, Behrmann C, Fleig WE: Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut 2005;54:1721-1727.
[PubMed]
https://doi.org/10.1136/gut.2005.069427
29.
Chong AK, Taylor A, Miller A, Hennessy O, Connell W, Desmond P: Capsule endoscopy versus push enteroscopy and enteroclysis in suspected small-bowel Crohn's disease. Gastrointest Endosc 2005;61:255-261.
[PubMed]
https://doi.org/10.1016/S0016-5107(04)02571-4
30.
Marmo R, Rotondano G, Piscopo R, Bianco MA, Siani A, Catalano O, Cipolletta L: Capsule endoscopy versus enteroclysis in the detection of small-bowel involvement in Crohn's disease: a prospective trial. Clin Gastroenterol Hepatol 2005;3:772-776.
[PubMed]
https://doi.org/10.1016/S1542-3565(05)00483-0
31.
Swain P: Wireless capsule endoscopy and Crohn's disease. Gut 2005;54:323-326.
[PubMed]
https://doi.org/10.1136/gut.2004.047282
32.
Voderholzer WA, Beinhoelzl J, Rogalla P, Murrer S, Schachschal G, Lochs H, Ortner MA: Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut 2005;54:369-373.
[PubMed]
https://doi.org/10.1136/gut.2004.040055
33.
Leighton JA, Triester SL, Sharma VK: Capsule endoscopy: a meta-analysis for use with obscure gastrointestinal bleeding and Crohn's disease. Gastrointest Endosc Clin N Am 2006;16:229-250.
[PubMed]
https://doi.org/10.1016/j.giec.2006.03.004
34.
Levesque BG: Yield to diagnostic accuracy: capsule endoscopy in Crohn's disease. Gastrointest Endosc 2010;71:128-130.
[PubMed]
https://doi.org/10.1016/j.gie.2009.07.008
35.
Doherty GA, Moss AC, Cheifetz AS: Capsule endoscopy for small-bowel evaluation in Crohn's disease. Gastrointest Endosc 2011;74:167-175.
[PubMed]
https://doi.org/10.1016/j.gie.2011.01.067
36.
Andre C, Descos L, Landais P, Fermanian J: Laboratory supplementation of Crohn's Disease Activity Index. Lancet 1980;2:594-595.
[PubMed]
https://doi.org/10.1016/S0140-6736(80)92032-2
37.
Andre C, Descos L, Landais P, Fermanian J: Assessment of appropriate laboratory measurements to supplement the Crohn's Disease Activity Index. Gut 1981;22:571-574.
[PubMed]
https://doi.org/10.1136/gut.22.7.571
38.
Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi GA: A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 1986;91:1490-1494.
[PubMed]
39.
Hyams JS, Mandel F, Ferry GD, Gryboski JD, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Boyle JT: Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992;14:216-222.
[PubMed]
https://doi.org/10.1097/00005176-199202000-00017
40.
Tromm A, Tromm CD, Hüppe D, Schwegler U, Krieg M, May B: Evaluation of different laboratory tests and activity indices reflecting the inflammatory activity of Crohn's disease. Scand J Gastroenterol 1992;27:774-778.
[PubMed]
https://doi.org/10.3109/00365529209011182
41.
Moran A, Jones A, Asquith P: Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis. Scand J Gastroenterol 1995;30:356-360.
[PubMed]
https://doi.org/10.3109/00365529509093290
42.
Sipponen T, Savilahti E, Kärkkäinen P, Kolho KL, Nuutinen H, Turunen U, Färkkilä M: Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-α therapy for Crohn's disease. Inflamm Bowel Dis 2008;14:1392-1398.
[PubMed]
https://doi.org/10.1002/ibd.20490
43.
Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F: Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010;105:162-169.
[PubMed]
https://doi.org/10.1038/ajg.2009.545
44.
Sipponen T, Björkesten CG, Färkkilä M, Nuutinen H, Savilahti E, Kolho KL: Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment. Scand J Gastroenterol 2010;45:325-331.
[PubMed]
https://doi.org/10.3109/00365520903483650
45.
Zubcevic N, Mesihovic R, Zubcevic S: Usefulness of laboratory data in estimation of Crohn's disease activity. Med Arh 2010;64:33-36.
[PubMed]
46.
Laharie D, Mesli S, El Hajbi F, Chabrun E, Chanteloup E, Capdepont M, Razaire S, de Lédinghen V, Zerbib F: Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study. Aliment Pharmacol Ther 2011;34:462-469.
[PubMed]
https://doi.org/10.1111/j.1365-2036.2011.04743.x
47.
Fagan EA, Dyck RF, Maton PN, Hodgson HJ, Chadwick VS, Petrie A, Pepys MB: Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982;12:351-359.
[PubMed]
https://doi.org/10.1111/j.1365-2362.1982.tb02244.x
48.
Boirivant M, Leoni M, Tariciotti D, Fais S, Squarcia O, Pallone F: The clinical significance of serum C-reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol 1988;10:401-405.
[PubMed]
https://doi.org/10.1097/00004836-198808000-00011
49.
Chamouard P, Richert Z, Meyer N, Rahmi G, Baumann R: Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease. Clin Gastroenterol Hepatol 2006;4:882-887.
[PubMed]
https://doi.org/10.1016/j.cgh.2006.02.003
50.
Franchimont D: C-reactive protein: informative or misleading marker of Crohn's disease? Inflamm Bowel Dis 2007;13:501-502.
[PubMed]
https://doi.org/10.1002/ibd.20123
51.
Tilakaratne S, Lemberg DA, Leach ST, Day AS: C-reactive protein and disease activity in children with Crohn's disease. Dig Dis Sci 2010;55:131-136.
[PubMed]
https://doi.org/10.1007/s10620-009-1017-8
52.
Florin TH, Paterson EW, Fowler EV, Radford-Smith GL: Clinically active Crohn's disease in the presence of a low C-reactive protein. Scand J Gastroenterol 2006;41:306-311.
[PubMed]
https://doi.org/10.1080/00365520500217118
53.
Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M: Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's Disease Activity Index and endoscopic findings. Inflamm Bowel Dis 2008;14:40-46.
[PubMed]
https://doi.org/10.1002/ibd.20312
54.
Maconi G, Parente F, Bollani S, Cesana B, Bianchi Porro G: Abdominal ultrasound in the assessment of extent and activity of Crohn's disease: clinical significance and implication of bowel wall thickening. Am J Gastroenterol 1996;91:1604-1609.
[PubMed]
55.
Haber HP, Busch A, Ziebach R, Stern M: Bowel wall thickness measured by ultrasound as a marker of Crohn's disease activity in children. Lancet 2000;355:1239-1240.
[PubMed]
https://doi.org/10.1016/S0140-6736(00)02092-4
56.
Castiglione F, de Sio I, Cozzolino A, Rispo A, Manguso F, Del Vecchio Blanco G, Di Girolamo E, Castellano L, Ciacci C, Mazzacca G: Bowel wall thickness at abdominal ultrasound and the one-year-risk of surgery in patients with Crohn's disease. Am J Gastroenterol 2004;99:1977-1983.
[PubMed]
https://doi.org/10.1111/j.1572-0241.2004.40267.x
57.
Parente F, Greco S, Molteni M, Anderloni A, Maconi G, Bianchi Porro G: Modern imaging of Crohn's disease using bowel ultrasound. Inflamm Bowel Dis 2004;10:452-461.
[PubMed]
https://doi.org/10.1097/00054725-200407000-00022
58.
Sturm EJ, Cobben LP, Meijssen MA, van der Werf SD, Puylaert JB: Detection of ileocecal Crohn's disease using ultrasound as the primary imaging modality. Eur Radiol 2004;14:778-782.
[PubMed]
https://doi.org/10.1007/s00330-003-2204-1
59.
Girlich C, Schacherer D, Jung EM, Schreyer A, Büttner R: Comparison between a clinical activity index (Harvey-Bradshaw Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohn's disease. Eur J Radiol 2012;81:1105-1109.
[PubMed]
https://doi.org/10.1016/j.ejrad.2011.02.054
60.
Kerber GW, Greenberg M, Rubin JM: Computed tomography evaluation of local and extraintestinal complications of Crohn's disease. Gastrointest Radiol 1984;9:143-148.
[PubMed]
https://doi.org/10.1007/BF01887821
61.
Gore RM, Cohen MI, Vogelzang RL, Neiman HL, Tsang TK: Value of computed tomography in the detection of complications of Crohn's disease. Dig Dis Sci 1985;30:701-709.
[PubMed]
https://doi.org/10.1007/BF01320482
62.
Colombel JF, Solem CA, Sandborn WJ, Booya F, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Bodily KD, Fletcher JG: Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C-reactive protein. Gut 2006;55:1561-1567.
[PubMed]
https://doi.org/10.1136/gut.2005.084301
63.
Schreyer AG, Geissler A, Albrich H, Schölmerich J, Feuerbach S, Rogler G, Völk M, Herfarth H: Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn's disease. Clin Gastroenterol Hepatol 2004;2:491-497.
[PubMed]
https://doi.org/10.1016/S1542-3565(04)00168-5
64.
Schreyer AG, Gölder S, Scheibl K, Völk M, Lenhart M, Timmer A, Schölmerich J, Feuerbach S, Rogler G, Herfarth H, Seitz J: Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn's disease: first clinical experience. Inflamm Bowel Dis 2005;11:388-394.
[PubMed]
https://doi.org/10.1097/01.MIB.0000164022.72729.06
65.
Gourtsoyiannis NC, Grammatikakis J, Papamastorakis G, Koutroumbakis J, Prassopoulos P, Rousomoustakaki M, Papanikolaou N: Imaging of small intestinal Crohn's disease: comparison between MR enteroclysis and conventional enteroclysis. Eur Radiol 2006;16:1915-1925.
[PubMed]
https://doi.org/10.1007/s00330-006-0248-8
66.
Malagò R, Manfredi R, Benini L, D'Alpaos G, Mucelli RP: Assessment of Crohn's disease activity in the small bowel with MR-enteroclysis: clinico-radiological correlations. Abdom Imaging 2008;33:669-675.
[PubMed]
https://doi.org/10.1007/s00261-008-9368-8
67.
Koilakou S, Sailer J, Peloschek P, Ferlitsch A, Vogelsang H, Miehsler W, Fletcher J, Turetschek K, Schima W, Reinisch W: Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm Bowel Dis 2010;16:198-203.
[PubMed]
https://doi.org/10.1002/ibd.21003
68.
Schreyer AG, Hoffstetter P, Daneschnejad M, Jung EM, Pawlik M, Friedrich C, Fellner C, Strauch U, Klebl F, Herfarth H, Zorger N: Comparison of conventional abdominal CT with MR enterography in patients with active Crohn's disease and acute abdominal pain. Acad Radiol 2010;17:352-357.
[PubMed]
https://doi.org/10.1016/j.acra.2009.10.023
69.
Herfarth H, Palmer L: Risk of radiation and choice of imaging. Dig Dis 2009;27:278-284.
[PubMed]
https://doi.org/10.1159/000228561
70.
Palmer L, Herfarth H, Porter CQ, Fordham LA, Sandler RS, Kappelman MD: Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases. Am J Gastroenterol 2009;104:2816-2823.
[PubMed]
https://doi.org/10.1038/ajg.2009.480
71.
Papay P, Ignjatovic A, Karmiris K, Amarante H, Milheller P, Feagan B, D'Haens G, Marteau P, Reinisch W, Sturm A, Steinwurz F, Egan L, Panés J, Louis E, Colombel JF, Panaccione R: Optimising monitoring in the management of Crohn's disease: a physician's perspective. J Crohns Colitis 2013;7:653-669.
[PubMed]
https://doi.org/10.1016/j.crohns.2013.02.005
72.
Brenner DJ, Hall EJ: Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357:2277-2284.
[PubMed]
https://doi.org/10.1056/NEJMra072149
73.
Berrington de González A, Darby S: Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet 2004;363:345-351.
[PubMed]
https://doi.org/10.1016/S0140-6736(04)15433-0
74.
Doll R, Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-1308.
[PubMed]
75.
Peloquin JM, Pardi DS, Sandborn WJ, Fletcher JG, McCollough CH, Schueler BA, Kofler JA, Enders FT, Achenbach SJ, Loftus EV Jr: Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:2015-2022.
[PubMed]
https://doi.org/10.1111/j.1572-0241.2008.01920.x
76.
Masselli G, Casciani E, Polettini E, Gualdi G: Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur Radiol 2008;18:438-447.
[PubMed]
https://doi.org/10.1007/s00330-007-0763-2
77.
Makó EK, Mester AR, Tarján Z, Karlinger K, Tóth G: Enteroclysis and spiral CT examination in diagnosis and evaluation of small bowel Crohn's disease. Eur J Radiol 2000;35:168-175.
[PubMed]
https://doi.org/10.1016/S0720-048X(00)00239-4
78.
Sailer J, Peloschek P, Schober E, Schima W, Reinisch W, Vogelsang H, Wunderbaldinger P, Turetschek K: Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's disease. AJR Am J Roentgenol 2005;185:1575-1581.
[PubMed]
https://doi.org/10.2214/AJR.04.1534
79.
Kohli MD, Maglinte DD: CT enteroclysis in small bowel Crohn's disease. Eur J Radiol 2009;69:398-403.
[PubMed]
https://doi.org/10.1016/j.ejrad.2008.11.022
80.
Gatta G, Di Grezia G, Di Mizio V, Landolfi C, Mansi L, De Sio I, Rotondo A, Grassi R: Crohn's disease imaging: a review. Gastroenterol Res Pract 2012, DOI: 10.1155/2012/816920. Epub 2012 Jan 18.
[PubMed]
https://doi.org/10.1155/2012/816920
81.
Herfarth HH, Grunert M, Klebl F, Strauch U, Feuerbach S, Schölmerich J, Rogler G, Schreyer AG: Frequency and nature of incidental extra-enteric lesions found on magnetic resonance enterography (MR-E) in patients with inflammatory bowel diseases (IBD). PLoS One 2009;4:e4863.
[PubMed]
https://doi.org/10.1371/journal.pone.0004863
82.
Rafal RB, Nichols JN, Cennerazzo WJ, Kazam E, DeCosse JJ: MRI for evaluation of perianal inflammation. Abdom Imaging 1995;20:248-252.
[PubMed]
https://doi.org/10.1007/BF00200407
83.
Borley NR, Mortensen NJ, Jewell DP: MRI scanning in perianal Crohn's disease: an important diagnostic adjunct. Inflamm Bowel Dis 1999;5:231-233; discussion 234.
[PubMed]
https://doi.org/10.1097/00054725-199908000-00012
84.
Szurowska E, Wypych J, Izycka-Swieszewska E: Perianal fistulas in Crohn's disease: MRI diagnosis and surgical planning: MRI in fistulazing perianal Crohn's disease. Abdom Imaging 2007;32:705-718.
[PubMed]
https://doi.org/10.1007/s00261-007-9188-2
85.
Wise PE, Schwartz DA: The evaluation and treatment of Crohn perianal fistulae: EUA, EUS, MRI, and other imaging modalities. Gastroenterol Clin North Am 2012;41:379-391.
[PubMed]
https://doi.org/10.1016/j.gtc.2012.01.009
86.
Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ, Zinsmeister AR, Norton ID, Boardman LA, Devine RM, Wolff BG, Young-Fadok TM, Diehl NN, Pemberton JH, Sandborn WJ: A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001;121:1064-1072.
[PubMed]
https://doi.org/10.1053/gast.2001.28676
87.
Schwartz DA, White CM, Wise PE, Herline AJ: Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas. Inflamm Bowel Dis 2005;11:727-732.
[PubMed]
https://doi.org/10.1097/01.MIB.0000172811.57242.18
88.
Maconi G, Ardizzone S, Greco S, Radice E, Bezzio C, Bianchi Porro G: Transperineal ultrasound in the detection of perianal and rectovaginal fistulae in Crohn's disease. Am J Gastroenterol 2007;102:2214-2219.
[PubMed]
https://doi.org/10.1111/j.1572-0241.2007.01441.x
89.
Losco A, Viganò C, Conte D, Cesana BM, Basilisco G: Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-assisted anal ultrasound. Inflamm Bowel Dis 2009;15:742-749.
[PubMed]
https://doi.org/10.1002/ibd.20826
90.
Rosen MJ, Moulton DE, Koyama T, Morgan WM 3rd, Morrow SE, Herline AJ, Muldoon RL, Wise PE, Polk DB, Schwartz DA: Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohn's disease. Inflamm Bowel Dis 2010;16:461-468.
[PubMed]
https://doi.org/10.1002/ibd.21067
91.
Lahat A, Assulin Y, Beer-Gabel M, Chowers Y: Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy. J Crohns Colitis 2012;6:311-316.
[PubMed]
https://doi.org/10.1016/j.crohns.2011.09.001
92.
Siddiqui MR, Ashrafian H, Tozer P, Daulatzai N, Burling D, Hart A, Athanasiou T, Phillips RK: A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Dis Colon Rectum 2012;55:576-585.
[PubMed]
https://doi.org/10.1097/DCR.0b013e318249d26c
93.
Pallotta N, Baccini F, Corazziari E: Small intestine contrast ultrasonography (SICUS) in the diagnosis of small intestine lesions. Ultrasound Med Biol 2001;27:335-341.
[PubMed]
https://doi.org/10.1016/S0301-5629(00)00356-2
94.
Ripollés T, Martínez-Pérez MJ, Blanc E, Delgado F, Vizuete J, Paredes JM, Vilar J: Contrast-enhanced ultrasound (CEUS) in Crohn's disease: technique, image interpretation and clinical applications. Insights Imaging 2011;2:639-652.
[PubMed]
https://doi.org/10.1007/s13244-011-0124-1
95.
De Franco A, Marzo M, Felice C, Pugliese D, Veronica AD, Bonomo L, Armuzzi A, Guidi L: Ileal Crohn's disease: CEUS determination of activity. Abdom Imaging 2012;37:359-368.
[PubMed]
https://doi.org/10.1007/s00261-011-9831-9
96.
Pallotta N, Vincoli G, Montesani C, Chirletti P, Pronio A, Caronna R, Ciccantelli B, Romeo E, Marcheggiano A, Corazziari E: Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in Crohn's disease: a prospective comparative study versus intraoperative findings. Inflamm Bowel Dis 2012;18:74-84.
[PubMed]
https://doi.org/10.1002/ibd.21678
97.
Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A: Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study. Eur J Gastroenterol Hepatol 2010;22:340-345.
[PubMed]
https://doi.org/10.1097/MEG.0b013e32832bab49
98.
De Bona M, Bellumat A, Cian E, Valiante F, Moschini A, De Boni M: Capsule endoscopy findings in patients with suspected Crohn's disease and biochemical markers of inflammation. Dig Liver Dis 2006;38:331-335.
[PubMed]
https://doi.org/10.1016/j.dld.2006.02.004
99.
Erber WF, Erber JA: Meta-analysis of the yield of capsule endoscopy in patients with Crohn's disease. Am J Gastroenterol 2006;101:2669.
[PubMed]
https://doi.org/10.1111/j.1572-0241.2006.00809_8.x
100.
Eliakim R: The impact of capsule endoscopy on Crohn's disease. Dig Liver Dis 2007;39:154-155.
[PubMed]
https://doi.org/10.1016/j.dld.2006.11.002
101.
Figueiredo P, Almeida N, Lopes S, Duque G, Freire P, Lérias C, Gouveia H, Sofia C: Small-bowel capsule endoscopy in patients with suspected Crohn's disease - diagnostic value and complications. Diagn Ther Endosc 2010;2010:101284.
[PubMed]
https://doi.org/10.1155/2010/101284
102.
Kiss LS, Papp M, Lovasz BD, Vegh Z, Golovics PA, Janka E, Varga E, Szathmari M, Lakatos PL: High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification? Inflamm Bowel Dis 2012;18:1647-1654.
[PubMed]
https://doi.org/10.1002/ibd.21933
103.
Prantera C, Luzi C, Olivotto P, Levenstein S, Cerro P, Fanucci A: Relationship between clinical and laboratory parameters and length of lesion in Crohn's disease of small bowel. Dig Dis Sci 1984;29:1093-1097.
[PubMed]
https://doi.org/10.1007/BF01317082
104.
Wright JM, Adams SP, Gribble MJ, Bowie WR: Clostridium difficile in Crohn's disease. Can J Surg 1984;27:435-437.
[PubMed]
105.
Kurtz LE, Yang SS, Bank S: Clostridium difficile-associated small bowel enteritis after total proctocolectomy in a Crohn's disease patient. J Clin Gastroenterol 2010;44:76-77.
[PubMed]
https://doi.org/10.1097/MCG.0b013e3181a7481b
106.
Adani GL, Avital I, Ferraresso C, Aoki T: CMV infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001;96:3464-3465.
[PubMed]
https://doi.org/10.1111/j.1572-0241.2001.05360.x
107.
Shahani L: CMV infection complicating the diagnosis of Crohn's disease in an immunocompetent patient. BMJ Case Rep 2012, DOI: 10.1136/bcr.11.2011.5254.
[PubMed]
https://doi.org/10.1136/bcr.11.2011.5254
108.
Sempere GA, Martinez Sanjuan V, Medina Chulia E, Benages A, Tome Toyosato A, Canelles P, Bulto A, Quiles F, Puchades I, Cuquerella J, Celma J, Orti E: MRI evaluation of inflammatory activity in Crohn's disease. AJR Am J Roentgenol 2005;184:1829-1835.
[PubMed]
https://doi.org/10.2214/ajr.184.6.01841829
109.
Martínez MJ, Ripollés T, Paredes JM, Blanc E, Martí-Bonmatí L: Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI. Abdom Imaging 2009;34:141-148.
[PubMed]
https://doi.org/10.1007/s00261-008-9365-y
110.
Maccioni F, Viola F, Carrozzo F, Di Nardo G, Pino AR, Staltari I, Al Ansari N, Vestri A, Signore A, Marini M, Cucchiara S: Differences in the location and activity of intestinal Crohn's disease lesions between adult and paediatric patients detected with MRI. Eur Radiol 2012;22:2465-2477.
[PubMed]
https://doi.org/10.1007/s00330-012-2482-6
111.
Biancone L, Calabrese E, Petruzziello C, Onali S, Caruso A, Palmieri G, Sica GS, Pallone F: Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease. Inflamm Bowel Dis 2007;13:1256-1265.
[PubMed]
https://doi.org/10.1002/ibd.20199
112.
Brenner DJ: Should computed tomography be the modality of choice for imaging Crohn's disease in children? The radiation risk perspective. Gut 2008;57:1489-1490.
[PubMed]
https://doi.org/10.1136/gut.2008.156265
113.
Siddiki H, Fletcher JG, Hara AK, Kofler JM, McCollough CH, Fidler JL, Guimaraes L, Huprich JE, Sandborn WJ, Loftus EV Jr, Mandrekar J, Bruining DH: Validation of a lower radiation computed tomography enterography imaging protocol to detect Crohn's disease in the small bowel. Inflamm Bowel Dis 2011;17:778-786.
[PubMed]
https://doi.org/10.1002/ibd.21364
114.
Mendoza JL: Ionizing radiation in Crohn's disease. Rev Esp Enferm Dig 2012;104:449-451.
[PubMed]
115.
Maconi G, Sampietro GM, Parente F, Pompili G, Russo A, Cristaldi M, Arborio G, Ardizzone S, Matacena G, Taschieri AM, Bianchi Porro G: Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am J Gastroenterol 2003;98:1545-1555.
[PubMed]
https://doi.org/10.1111/j.1572-0241.2003.07521.x
116.
Paparo F, Bacigalupo L, Garello I, Biscaldi E, Cimmino MA, Marinaro E, Rollandi GA: Crohn's disease: prevalence of intestinal and extraintestinal manifestations detected by computed tomography enterography with water enema. Abdom Imaging 2012;37:326-337.
[PubMed]
https://doi.org/10.1007/s00261-011-9832-8
117.
Tarján Z, Tóth G, Györke T, Mester A, Karlinger K, Makó EK: Ultrasound in Crohn's disease of the small bowel. Eur J Radiol 2000;35:176-182.
[PubMed]
https://doi.org/10.1016/S0720-048X(00)00240-0
118.
Rigazio C, Ercole E, Laudi C, Daperno M, Lavagna A, Crocella L, Bertolino F, Viganò L, Sostegni R, Pera A, Rocca R: Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: proposal of an ultrasonographic score. Scand J Gastroenterol 2009;44:585-593.
[PubMed]
https://doi.org/10.1080/00365520802705992
119.
Rutgeerts P, Diamond RH, Bala M, Olson A, Lichtenstein GR, Bao W, Patel K, Wolf DC, Safdi M, Colombel JF, Lashner B, Hanauer SB: Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006;63:433-442; quiz 464.
[PubMed]
https://doi.org/10.1016/j.gie.2005.08.011
120.
Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P: Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009;15:1295-1301.
[PubMed]
https://doi.org/10.1002/ibd.20927
121.
Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, Stokkers P, Hommes D, Rutgeerts P, Vermeire S, D'Haens G: Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010;138:463-468; quiz e410-e461.
[PubMed]
https://doi.org/10.1053/j.gastro.2009.09.056
122.
Flynn A, Kane S: Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us? Curr Opin Gastroenterol 2011;27:342-345.
[PubMed]
https://doi.org/10.1097/MOG.0b013e3283455c8f
123.
Danese S, Peyrin-Biroulet L: IBD: mucosal healing - EXTENDing our knowledge in Crohn's disease. Nat Rev Gastroenterol Hepatol 2012;9:309-311.
[PubMed]
https://doi.org/10.1038/nrgastro.2012.77
124.
De Cruz P, Kamm MA, Prideaux L, Allen PB, Moore G: Mucosal healing in Crohn's disease: a systematic review. Inflamm Bowel Dis 2013;19:429-444.
[PubMed]
https://doi.org/10.1002/ibd.22977
125.
Peyrin-Biroulet L, Danese S: Stopping infliximab in Crohn's disease: still an ongoing STORI. Inflamm Bowel Dis 2012;18:2201-2202.
[PubMed]
https://doi.org/10.1002/ibd.23016
126.
Rutgeerts P: Strategies in the prevention of post-operative recurrence in Crohn's disease. Best Pract Res Clin Gastroenterol 2003;17:63-73.
[PubMed]
https://doi.org/10.1053/bega.2002.0358
127.
Pascua M, Su C, Lewis JD, Brensinger C, Lichtenstein GR: Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn's disease. Aliment Pharmacol Ther 2008;28:545-556.
[PubMed]
https://doi.org/10.1111/j.1365-2036.2008.03774.x
128.
Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC: Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009;4:CD006873, DOI: 10.1002/14651858.CD006873.pub2. Review.
[PubMed]
https://doi.org/10.1002/14651858.CD006873.pub2
129.
D'Haens GR, Rutgeerts PL: Postoperative recurrence of Crohn's disease: pathogenesis and prevention. Acta Gastroenterol Belg 1994;57:311-313.
[PubMed]
130.
Rutgeerts P: Clinical risk factors determining recurrence in Crohn's disease. Gastroenterol Hepatol 1996;19:44-46.
[PubMed]
131.
D'Haens G, Rutgeerts P: Postoperative recurrence of Crohn's disease: pathophysiology and prevention. Inflamm Bowel Dis 1999;5:295-303.
[PubMed]
https://doi.org/10.1097/00054725-199911000-00010
132.
Van Assche G, Rutgeerts P: Medical management of postoperative recurrence in Crohn's disease. Gastroenterol Clin North Am 2004;33:347-360.
[PubMed]
https://doi.org/10.1016/j.gtc.2004.02.012
133.
Rutgeerts P: Recurrence of Crohn's disease after surgery - the need for treatment of new lesions. Aliment Pharmacol Ther 2006;24(suppl 3):29-32.
[PubMed]
https://doi.org/10.1111/j.1365-2036.2006.03056.x
134.
Orlando A, Modesto I, Castiglione F, Scala L, Scimeca D, Rispo A, Teresi S, Mocciaro F, Criscuoli V, Marrone C, Platania P, De Falco T, Maisano S, Nicoli N, Cottone M: The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound. Eur Rev Med Pharmacol Sci 2006;10:17-22.
[PubMed]
135.
Lamb CA, Mohiuddin MK, Gicquel J, Neely D, Bergin FG, Hanson JM, Mansfield JC: Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br J Surg 2009;96:663-674.
[PubMed]
https://doi.org/10.1002/bjs.6593
136.
Seibold F, Schoepfer AM: Can fecal calprotectin or lactoferrin identify postoperative recurrence in Crohn's disease? Inflamm Bowel Dis 2010;16:1814-1815.
[PubMed]
https://doi.org/10.1002/ibd.21173
© 2014 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2014
You do not currently have access to this content.